Posts in category Business Standard
EaseMyTrip.com inks MoU with UP tourism board to boost state’s eco-tourism (01-07-2024)
Easy Trip Planners said that it has signed a memorandum of understanding (MoU) with Uttar Pradesh EcoTourism Development Board (UPETDB) under the Government of Uttar Pradesh.
US Equities End Mixed For The Week (01-07-2024)
U.S. stocks gave up early gains to end lower on Friday. After reaching record intraday highs, the Nasdaq slid 126.08 points or 0.7 percent to 17,732.60 and the S&P 500 fell 22.39 points or 0.4 percent to 5,460.48. The narrower Dow posted a more modest loss, edging down 45.20 points or 0.1 percent to 39,118.86. For the week, the Nasdaq rose by 0.2 percent but the Dow and the S&P 500 both edged down by 0.1 percent. However, the Nasdaq and the S&P 500 posted substantial gains for the first half.
Orchid Pharma rises 4% on deal with Cipla to roll out new UTI drug in India (01-07-2024)
The rise came following Orchid Pharma's announcement of a collaboration with pharmaceutical giant Cipla to introduce the antibiotic Cefepime-Enmetazobactam in India
Indian govt bond yields marginally higher tracking US Treasury moves (01-07-2024)
US yields rose on Friday and gained further during Asia hours as uncertainty around the US presidential election
Asian Paints expands capacity at Mysuru plant to 6,00,000 KL (01-07-2024)
Asian Paints announced that the installed capacity of the Mysuru plant has been doubled to 6,00,000 KL per annum in order to meet the medium-term capacity requirements of the company with an investment of Rs 1,305 crore.
Ion Exchange (India) soars after Nippon MF ups stake (01-07-2024)
Ion Exchange (India) soared 14.22% to Rs 656.90 after Nippon India Mutual Fund, a leading asset manager in India, increased its stake in the company.
Alembic Pharma spurts on USFDA nod for leukemia drug (01-07-2024)
Alembic Pharmaceuticals rallied 4.43% to Rs 915.25 after the company said that it has received a tentative approval from US Food & Drug Administration (US FDA) for its abbreviated new drug application (ANDA) for Bosutinib tablets.
Volumes soar at J B Chemicals & Pharmaceuticals Ltd counter (01-07-2024)
J B Chemicals & Pharmaceuticals Ltd clocked volume of 43579 shares by 10:47 IST on BSE, a 7.11 times surge over two-week average daily volume of 6127 shares
IREDA gains after loans sanctions zoom to Rs 9,136 crore in Q1FY25 (01-07-2024)
Indian Renewable Energy Development Agency (IREDA) advanced 3.54% to Rs 197.20 after the company's loan sanctions stood Rs 9,136 crore in the June quarter, steeply higher than Rs 1,893 crore in the June quarter of last year.
Alembic Pharmaceuticals receives USFDA tentative approval for Bosutinib tablets (01-07-2024)
Alembic Pharmaceuticals has received tentative approval from the US Food & Drug Administration (USFDA) for Bosutinib Tablets, 100 mg and 500 mg.